Boustead takes over Pharmaniaga for RM534m
In its first major foray into the healthcare sector, the conglomerate will buy UEM Group’s entire 86.8 per cent stake in Pharmaniaga for RM5.75 a share.
In its first major foray into the healthcare sector, the conglomerate will buy UEM Group’s entire 86.8 per cent stake in Pharmaniaga for RM5.75 a share.
In its first major foray into the healthcare sector, the conglomerate will buy UEM Group’s entire 86.8 per cent stake in Pharmaniaga for RM5.75 a share.
David Lundin has been named senior vice president and production manager for Needham-based commercial real estate investment management firm CWCapital’s Northeast FHA lending operations.
In its first major foray into the healthcare sector, the conglomerate will buy UEM Group’s entire 86.8 per cent stake in Pharmaniaga for RM5.75 a share.
The conglomerate said yesterday it would buy UEM Group Bhd’s entire 86.8 per cent stake in Pharmaniaga for RM534 million cash, or RM5.75 a share. This is a 12.7 per cent premium over Pharmaniaga’s last traded price of RM5.10 on Thursday. Boustead later plans to make a mandatory general offer for the rest of the shares it doesn’t own “at a comparable price”, group managing director Tan Sri Lodin …
BOSTON—-CWCapital, a full-service national lender to the multifamily and healthcare real estate industries, today announced it has appointed David Lundin as Senior Vice President and Production Manager for the firms Northeast FHA lending operations.
BOSTON—-CWCapital, a full-service national lender to the multifamily and healthcare real estate industries, today announced it has appointed David Lundin as Senior Vice President and Production Manager for the firms Northeast FHA lending operations.
Steve Hartman, E-Z-EM’s corporate representative in the patent infringement jury trial of Tyco Healthcare Group LP, Mallinckrodt Inc. and Liebel-Flarsheim Company vs. E-Z-EM Inc., testified Thursday how hard E-Z-EM worked to develop its Empower CT injector systems, which were first sold in 2001.
Steve Hartman, E-Z-EM’s corporate representative in the patent infringement jury trial of Tyco Healthcare Group LP, Mallinckrodt Inc. and Liebel-Flarsheim Company vs. E-Z-EM Inc., testified Thursday how hard E-Z-EM worked to develop its Empower CT injector systems, which were first sold in 2001.